发明名称 |
CELL MEMBRANE-DIRECTED DRUGS |
摘要 |
Drugs wherein peptides having an affinity specific to phospholipids, preferably those which constitute a lipid bilayer forming a cell cortex and the content of which in the lipid bilayer increases in abnormal cells, for example, injured, denatured or activated cells are bonded to physiologically active substances; deoxyribonucleic acids (DNA) encoding the amino acid sequences of the drugs when the physiologically active substances are peptides; and processes for producing these drugs. These drugs and novel peptides are useful as preventives and remedies for diseases accompanied by blood coagulation disorders, inflammation and immune responses. |
申请公布号 |
EP0965597(A4) |
申请公布日期 |
2003.01.08 |
申请号 |
EP19980900156 |
申请日期 |
1998.01.05 |
申请人 |
MOCHIDA PHARMACEUTICAL CO., LTD. |
发明人 |
KURIYAMA, SHINICHI;HASEGAWA, TAKASHI |
分类号 |
A61K38/00;A61K47/48;C07K14/705;C07K14/745;C07K14/755;C07K14/81;C12N9/64;C12N15/12;C12P21/02 |
主分类号 |
A61K38/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|